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ABSTRACT
Background: Dermatophagoides farinae (Der f) is one of the most frequently implicated allergens in several
allergic diseases. Several genome-wide screens have identified a linkage between chromosome 6p21 and
mite-specific IgE responsiveness. Butyrophilin-like 2 (BTNL2) is a member of the immunoglobulin superfamily
and, on the basis of its homology to B7-1, has been implicated as a costimulatory molecule involved in T-cell
activation. BTNL2 resides in the HLA region on chromosome 6p21, and significant associations between
BTNL2 gene polymorphisms and several inflammatory diseases have been reported.
Objective: The aim of this study was to examine whether BTNL2 gene polymorphisms are associated with
specific IgE responses to Der f.
Methods: Three single nucleotide polymorphisms (SNPs), including 2 coding SNPs and 1 intron SNP, were
studied. One of the coding SNPs was the rs2076530 A > G, which has a functional consequence. A total of 863
unrelated Japanese subjects (447 positive and 416 negative for IgE to Der f) were recruited for a case-control
study.
Results: Controlling for gender, age, smoking, and the presence of asthma, multiple logistic regression analy-
ses showed that homozygosity of the rs2076530 A allele, which has been reported to be a risk allele for sarcoi-
dosis, was associated with a risk of sensitization towards Der f (Odds ratio; 1.55, p = 0.0060).
Conclusions: Although an association which may be due to the linkage disequilibrium with other genes in 6p
21 needs to be ruled out, the present findings suggest that the BTNL2 gene might be one of the candidate
genes that is responsible for the pathogenesis of Der f-specific IgE responsiveness.
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INTRODUCTION
Dermatophagoides farinae (Der f) is one of the most
frequently implicated allergens in several allergic dis-
eases. Antibody responsiveness to complex allergens
such as Der f is considered to be a multifactorial trait
because it is controlled by both genetic and environ-
mental factors.1,2 In genome-wide screening, chromo-
some 6p21 has been shown to be linked to mite-
specific IgE responsiveness, where the HLA class II
gene location suggests evidence for being a strong
candidate for the trait.3-5 A number of studies have
shown that specific IgE production in response to in-
dividual allergens is associated with particular HLA
class II alleles, exclusively for low-molecular-weight
allergens such as Ambrosia artemisifolia V (Amb a 5)
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Table 1 Primers for direct sequencing
Primer sequenceName of primer
5’ TGAGTGCAAC CTGGGATACT G 3’6813 Forward
5’ TCTCCCACCT GACAGGAAGC 3’6813 Reverse
5’ CAGACTGACACACATCATGGAATG 3’11084 Forward
5’ ACAGTGGGAAATGATGCTGC 3’11084 Reverse
5’ AGTGAAATTGCTGCCCACTC 3’12155 Forward
5’ TCGTCTTTCCTTCCATGTCC 3’12155 Reverse
and Lolium Perenne pollen III (Lol p 3) (molecular
weight, about 5 kD).6-8 However, in the case of very
complex allergens such as Der f (molecular weight,
25 kD), genetic regulation of the immune response
by HLA genes is known to be quite complex; it in-
volves multiple epitopes and agretopes,9,10 which in-
evitably dilutes any association between particular
HLA class II alleles and specific IgE responses to a
given complex allergen. Marsh et al. postulated the
existence of an HLA-associated hyperresponsiveness
state controlled by an additional genetic factor re-
sponsible for the overall expression of the immune
response.11 Therefore, although a particular HLA
class II allele is responsible for the development of
IgE responses to Der f, susceptibility may be related
more to generalized hyperresponsiveness than to
specific responses to Der f.
BTNL2, also known as “butyrophilin-like 2” and
“BTL-2”, is a butyrophilin gene that belongs to the
immunoglobulin gene superfamily. On the basis of its
amino acid homology to B7 (CD80 and CD86) pro-
teins, BTNL2 has been proposed to play a role as a
costimulatory receptor involved in modulation of T-
cell responses.12,13 Recent in vivo studies using
BTNL2-Immunogloburin (Ig) have demonstrated that
BTNL2 binds to a putative receptor on activated T
cells and functions to inhibit the proliferation of T
cells,14,15 suggesting that this gene plays an inhibi-
tory role in T cell activation.
The BTNL2 gene resides in the HLA region on
chromosome 6p21, and significant associations be-
tween BTNL2 gene polymorphisms and several in-
flammatory diseases have been reported.13,16-18 A
loss-of-function allele at rs2076530 in the BTNL2
gene has been implicated as a risk factor for sarcoido-
sis in two populations.13,19,20
Given the possible role of BTNL2 in the inhibition
of T cell activation, as well as its chromosomal loca-
tion, we hypothesized that it was a possible candidate
gene for Der f-specific IgE responsiveness. As part of
our search for genetic factors that contribute to sus-
ceptibility to atopy and asthma,3,21-23 the current
study focused on the BTNL2 gene. In particular, the
potentially functional BTNL2 gene polymorphism
(rs2076530) was correlated with the development of
Der f-specific IgE responses.
METHODS
STUDY POPULATION
A total of 863 unrelated Japanese subjects, including
424 asthma patients and 439 healthy volunteers, were
recruited. Total serum IgE levels (IUml) were meas-
ured in all subjects, and specific IgE responses to 10
common inhaled allergens, including Der f, grass pol-
len, animal danders, and molds were also assessed.
An increase in specific IgE antibody levels (IgE CAP
RAST > 0.35 UAml, or MAST > 1.0 lumicount) was
considered to indicate a positive response. Subjects
who showed a positive specific IgE response to Der f
(n = 447) included 259 asthma patients and 188
healthy volunteers, while subjects who did not dem-
onstrate a specific IgE response to Der f (n = 416) in-
cluded 165 asthma patients and 251 healthy volun-
teers. All asthma patients (n = 424) were recruited
from the pulmonary clinic of the First Department of
Medicine at the Hokkaido University Hospital.
Asthma was defined based on the presence of recur-
rent episodes of at least two of three symptoms
(cough, wheeze, or dyspnea) that were associated
with demonstrable reversible airflow limitation and
or increased airway responsiveness to methacholine,
as previously described.21-23 Individuals who visited
our clinic for annual routine physical examinations
and students at the Hokkaido University’s School of
Medicine were recruited as healthy controls (n = 446)
if they had no history of asthma or any other chronic
pulmonary diseases. Atopy was defined as a positive
response to at least 1 of the 10 common inhaled aller-
gens, as previously described.21-23 All subjects were
unrelated Japanese who gave their written informed
consent for enrollment in the study and all associated
procedures. The study was approved by the ethics
committee at the Hokkaido University School of
Medicine.
GENOTYPING
Six single nucleotide polymorphisms (SNPs) in the
BTNL2 gene (6813 A > G, 11084 A > G, 12155 C > T,
12159 G > A, 12197 C > A, and 12198 A > G) were se-
lected from previous reports13 and the public data-
base, SNPper.24 Nucleotide numbering was meas-
ured from the first nucleotide of the transcription
start site. The seven SNPs included the rs2076530
polymorphism (11084 A > G) in exon 5, which led to
an alternative splice site and resulted in an early stop
codon and a truncated protein, and four polymor-
phisms in the coding region (exon6) that caused the
following amino acid substitutions: 12155 C > T
(Pro285Leu); 12159 G > A (Met286Ile); 12197 C > A
(Pro299Gln); and 12198 A > G (Pro299Gln). Initially,
25 control subjects (i.e., 50 haploid genomes) were
genotyped by direct sequencing for each polymor-
phism. Since all of the polymorphisms had a minor al-
lele frequency of > 0.01 and the four SNPs in exon 6
BTNL2 Polymorphisms and Specific IgE
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Table 2 Primers for alele-specific PCR
Primer sequence＊Name of primer
5’ AGCACACCTTTCAGCCCACA 3’6813 Forward for A
5’ AGCACACCTTTCAGCCCACG 3’6813 Forward for G
5’ TGTGTTTGTTACCCTGATTTTCCTC 3’6813 Reverse
5’ CAGGAGGCCAGTTTGGATCTG 3’11084 Forward
5’ GCAGGTATTGAATACAAAATATCTATCTATCTAGAATTCTTACT 3’11084 Reverse for A
5’ GCAGGTATTGAATACAAAATATCTATCTATCTAGAATTCTTACC 3’11084 Reverse for G
5’ AAATGCAGCCGATGTGCTC 3’12155 Forward for C
5’ CCTTCCATGTCCCTCCAT 3’12155 Reverse for C
5’ GGAGAAATGCAGCTGATATGCTC 3’12155 Forward for T
5’ CCTTCCATGTCCCTCCAC 3’12155 Reverse for T
＊The nucleotide coresponding to each SNP is underlined.
Table 3 Basic characteristics of the study subjects
P value
Negative IgE to Der (n＝416) Positive IgE to Der f (n＝447) 　
ControlAsthmaControlAsthma
251165188259Number of subjects
＜ .001＊95/156103/6260/128129/130Gender (female/male) 
＜ .001＊43, 18―7257, 18―8127, 19―6933, 16―76Age (years, median, range) 
＜ .001＊30.921.223.724.1Curent smoker (%) 
＜ .001＊1.62 (0.58) 2.01 (0.60) 2.16 (0.54) 2.60 (0.60) Serum total IgE levels (log IU/ml, SD) 
Three SNPs genotyped
0.20†12083102143AA6813A＞G
rs3817963 1096767102AG
22151914GG
0.035†896186110AA11084A＞ G 
rs2076530 1097864101GA
53263848GG
0.97†1308599130CC12155C＞ T 
rs28362678 1037077112CT
18101217TT
＊One-way ANOVA or χ2 test as appropriate.
†P value from a genotype-based χ2 test of 2×3 data (positive IgE to Der f/negative IgE to Der f).
were in complete linkage disequilibrium, three SNPs
(6813 A > G, 11084 A > G, and 12155 C > T) were sub-
jected to further analyses. The sequences of the prim-
ers used for direct sequencing are shown in Table 1.
Alleles were identified using an assay combining ki-
netic (real-time quantitative) polymerase chain reac-
tion (PCR) with allele-specific amplification, as de-
scribed elsewhere.22,23 Primers were designed using
Primer Express software (PE Applied Biosystems,
Foster City, CA, USA) to specifically amplify each
SNP allele in separate PCRs. The sequences of the
primers used for allele-specific PCR are shown in Ta-
ble 2. Real-time PCR was performed using Syber
Green I Master Mix (Applied Biosystems) and an
ABI PRISM TM 7700 Sequence Detection System
(Applied Biosystems).
DATA ANALYSIS
All three SNPs were tested for conformation with
Hardy-Weinberg expectations (HWE) using Haplo-
view software, version 3.2.25 Statistical analyses were
based on the calculation of odds ratios to provide esti-
mates of the relative risk of sensitization to Der f. Lo-
gistic regression analysis was used to estimate odds
ratios adjusted by gender, age, and smoking status
(current, ex, or never). The linkage disequilibrium
(LD) structure was examined using Haploview soft-
ware.25 For haplotype analysis, we used the Haplo.
score program, which adjusts for covariates and cal-
culates p values for each haplotype.23,26
RESULTS
The characteristics of the subjects with specific IgE
Konno S et al.
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Table 4 Genetic impact on sensitization to Der f of three single nucleotide polymorphisms in the BTNL2 gene
Odds Ratio (95% CI)＊
GenotypeSNP
Adjusted†Unadjusted
ReferenceReferenceAA
6813A＞G
 (rs3817963)
0.77 (0.56―1.06)0.80 (0.60―1.06)AG
0.68 (0.38―1.16)0.74 (0.45―1.22)GG
ReferenceReferenceAA
0.75 (0.56―1.02)0.81 (0.50―1.33)AG or GG
ReferenceReferenceAA or AG
0.78 (0.45―1.33)0.78 (0.45―1.33)GG
ReferenceReferenceGG
11084A＞G
(rs2076530)
0.76 (0.50―1.15)0.84 (0.58―1.21)GA
1.30 (0.85―2.00)1.23 (0.84―1.77)AA
ReferenceReferenceGG
0.99 (0.67―1.45)1.01 (0.72―1.41)GA or AA
ReferenceReferenceGG or GA
1.55 (1.13―2.10)§1.38 (1.05―1.81)‡AA 
ReferenceReferenceCC 
12155C＞T
(rs28362678)
0.85 (0.62―1.16)1.03 (0.78―1.36)CT 
0.72 (0.38―1.34)0.91 (0.53―1.57)TT 
ReferenceReferenceCC 
0.83 (0.61―1.12)1.01 (0.78―1.32)CT or TT
ReferenceReferenceCC or CT
0.77 (0.42―1.41)0.90 (0.53―1.52)TT 
＊Odds Ratios were calculated using logistic regression analysis.
†The adjusted value was calculated after adjusting for gender, age, smoking status, and asthmatic status.
‡p＝0.021, §p＝0.0060.
responses to Der f (n = 447) and of the subjects with-
out specific IgE responses to Der f (n = 416) are
shown in Table 3. The median age of the subjects
with Der f-specific IgE responses was significantly
lower than that of the subjects without Der f-specific
IgE responses (p < 0.001). There were more asthma
patients in the positive Der f-specific IgE group (p <
0.001), and their total serum IgE levels were higher
than those of subjects without Der f-specific IgE (p <
0.001). The three SNPs investigated (6813 A > G,
11084 A > G, and 12155 C > T) were within the HWE
in subjects without Der f-specific IgE (p > 0.05). A sig-
nificant association between 11084 A > G [rs2076530]
and Der f sensitization was found when the analysis
was adjusted for age, gender, smoking status, and
asthmatic status (Table 4). The OR for the AA ho-
mozygotes of the 11084 A > G polymorphism was
1.55 compared with the other genotypes, GG ho-
mozygotes, or GA heterozygotes (95% CI, 1.13−2.10;
p = 0.0060).
Pair-wise linkage disequilibrium (LD) values for
the three SNPs are shown in Figure 1. The frequency
of the BTNL2 haplotypes is shown in the haplotype
tables (Table 5). The 6813G11084G12155C (GGC)
haplotype was associated with a significantly lower
risk of sensitization to Der f (p = 0.019) as judged by
haplotype-specific scores (Table 5).
In the case-control study, associations between
asthma-related phenotypes, such as total serum IgE
levels, atopy, asthma, and the polymorphisms of
BTNL2, were also investigated. No significant asso-
ciations between the genotypes of the three SNPs
and total serum IgE levels, atopy, or asthma were
found (data not shown).
DISCUSSION
In the present study, a significant association be-
tween BTNL2 gene polymorphisms and specific IgE
responses to Der f was identified in a Japanese popu-
lation.
In genome-wide screening, chromosome 6p21 has
been shown to be linked with mite-specific IgE re-
sponsiveness, and a strong association with the HLA
class II gene has been reported.3-5 Chromosome 6p21
contains several important genes involved in immu-
nological responses, and there is extensive linkage
disequilibrium (LD) within this region.27,28 There-
fore, it is still unclear whether the HLA genes deter-
BTNL2 Polymorphisms and Specific IgE
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Fig. 1 Location and linkage disequilibrium (LD) map struc-
ture of single-nucleotide polymorphisms (SNPs) in BTNL2. 
Haploview plot shows pairwise LD (D’ values) for 3 SNPs 
based on the genotypes of the 863 individuals in the case-
control study. Each square plots the level of LD (D’ values) 
between a pair of SNPs.
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mine susceptibility directly, or whether associations
may be due to other genes within this region. The as-
sociation between HLA class II antigens and the IgE
response was first noted in patients sensitized to
small, well-defined antigens, such as the ragweed al-
lergens Amb a 5 and the rye grass allergens Lol
p 3.6-8 Several recent studies have also demonstrated
HLA class II associations in industrial asthma, where
the triggering molecules are simple, low molecular
weight molecules such as isocyanates and acid anhy-
drides.29,30 On the other hand, high molecular weight
allergens such as Der f presumably express multiple
epitopes or sequence motifs that can each be pre-
sented in association with different HLA class II poly-
morphic molecules expressed on the surface of
antigen-presenting cells.9,10 This phenomenon inevi-
tably dilutes any association between particular HLA
class II alleles and specific IgE responses to a given
allergen in a population, particularly when whole al-
lergen extracts are used. The results of this study
support previous observations that non-HLA genes
may be of importance in controlling specific IgE-
responsiveness to complex allergens such as Der
f,31-33 and we demonstrated that BTNL2 is a possible
candidate gene.
The rs2076530 is located within a donor splice site
and the G to A nucleotide transition results in the re-
cruitment of an alternative splice site located four
base pairs upstream of the affected donor site. The
exclusion of the four base pairs from the spliced
mRNA transcript derived from the A allele produces a
frameshift and a premature stop codon in the follow-
ing downstream exon. It has been hypothesized that
the truncating polymorphism results in impairment of
a potential T-cell downregulatory function of BTNL2,
possibly by mis-localization from the membrane, lead-
ing to dysregulated T-helper cell activation.13 A loss-
of-function allele at rs2076530 in the BTNL2 gene has
been implicated as a risk factor for sarcoidosis,13,19,20
a disorder that probably results from an exaggerated
T-cell response to airborne antigens. In the present
study, we observed an increased prevalence of the
same dysfunctional allele in subjects with a positive
Der f-specific IgE response, indicating that BTNL2
might inhibit the production of Der f-specific IgE.
The interaction between dendritic cells and T cells
during allergen sensitization largely depends on a co-
ordinated process involving the main pathway of HLA
class IIantigen peptide complex to antigen-specific T
cell receptor (TCR) and the additional pathway in-
volving costimulatory molecules, including BTNL2.
Therefore, HLA class II alleles and BTNL2 alleles
might have cross-relationships, which might result in
an association between the BTNL2 gene and the Der
f-specific IgE response.
Even though the functional background of BTNL2
and rs2076530 has been reported, the significance of
genetic variants of the BTNL2 gene is complicated
because of extensive linkage disequilibrium (LD) in
chromosome 6p21. Indeed, it has been reported that
the effect of BTNL2 on susceptibility to multiple scle-
rosis,16 rheumatoid arthritis,17 systemic lupus erythe-
matosus,17 and Graves’ disease18 is secondary and is
simply due to linkage disequilibrium with some MHC
class II alleles. In addition to the HLA gene, chromo-
some 6p21 contains several important genes, such as
BTNL2, lymphotaxin-α (LTA), transporter, ATP-
binding cassette (TAP), tumor necrosis factor-α
(TNFA), retinoid X receptor B (RXRB), which are in-
volved in immunological and inflammatory responses
(Fig. 2). Therefore, it is necessary to ascertain
whether the association that was identified in the pre-
sent study is attributable to direct involvement of the
BTNL2 gene itself in disease pathogenesis or
whether this is merely a reflection of linkage dise-
quilibrium with one or more disease genes located on
adjacent areas of chromosome 6. Extensive recent
analyses have provided wider haplotype blocks
across the HLA region and a nearby locus in chromo-
some 6p21.27,28 Further extensive analyses using this
information will provide the answer and address the
limitations of our studies.
In conclusion, given that non-HLA genes in the
chromosome 6p21 region may be important for the
development of specific IgE responses to high mo-
lecular weight allergens, the functional relevance of
the BTNL2 polymorphisms, along with its chromoso-
mal location, strongly suggest that BTNL2 is an ex-
cellent candidate gene for the development of Der f-
specific IgE responsiveness. Further studies are
needed to clarify the pathological mechanisms by
Konno S et al.
34 Allergology International Vol 58, No1, 2009 www.jsaweb.jp
Fig. 2 Gene map and location of several important genes involved in immunological and inflammatory re-
sponses at 6p21. LTA, lymphotaxin-α; TNFA, tumor necrosis factor-α; CLIC, chloride intracelular channel;
C4, complement component 4; TAP, transporter, ATP-binding cassete; RXRB, retinoid X receptor B.
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Table 5 Association analysis of haplotypes in BTNL2 gene with sensitization to Der f
p valueHaplotype-specific Score
Haplotype Frequency＊　　　
Not sensi-
tized to Der f
Sensitized 
to Der f12155110846813Haplotype　
0.019－2.3520.1210.076CGG1
0.562－0.5520.1730.183TGG2
0.582－0.5310.0970.086TGA3
0.3550.9120.0190.030CGA4
0.0981.6450.5870.618CAA5
＊The frequency of each haplotype in 863 subjects was estimated using the Haplo.Stats program.26
Haplotypes with frequencies less than 1% are not listed.
Note that haplotype-specific scores give efect estimates, negative haplotype-specific scores are associated with a protective efect, 
and positive haplotype-specific scores are associated with an increased risk.
which BTNL2 contributes to the development of Der
f-specific IgE production.
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